Variant report
Variant | esv16456 |
---|---|
Chromosome Location | chr15:55129551-55137977 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs574683879 | chr15:55129563-55129564 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs543784919 | chr15:55129589-55129590 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs12591103 | chr15:55129594-55129595 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs138172231 | chr15:55129621-55129622 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs573999361 | chr15:55129631-55129632 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs143648995 | chr15:55129674-55129675 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs532616255 | chr15:55129722-55129723 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs8033480 | chr15:55129742-55129743 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs545363326 | chr15:55129789-55129790 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs2681991 | chr15:55129814-55129815 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs572560561 | chr15:55129838-55129839 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs374671174 | chr15:55129864-55129865 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs150135427 | chr15:55129867-55129868 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs59404883 | chr15:55129872-55129873 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs186957319 | chr15:55129912-55129913 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs115494583 | chr15:55129926-55129927 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs117565817 | chr15:55129936-55129937 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs531257264 | chr15:55129942-55129943 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs548537492 | chr15:55129969-55129970 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs2695651 | chr15:55129972-55129973 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs149269390 | chr15:55129976-55129977 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs371326671 | chr15:55130020-55130021 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs189752677 | chr15:55130039-55130040 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs567486047 | chr15:55130070-55130071 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs536837116 | chr15:55130125-55130126 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs556606631 | chr15:55130137-55130138 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs570324927 | chr15:55130153-55130154 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs538697005 | chr15:55130157-55130158 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs144468406 | chr15:55130162-55130163 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs139098851 | chr15:55130172-55130173 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs572573719 | chr15:55130224-55130225 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs541506337 | chr15:55130245-55130246 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs375932327 | chr15:55130269-55130270 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs74379379 | chr15:55130279-55130280 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs542807426 | chr15:55130302-55130303 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs77799373 | chr15:55130349-55130350 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs569568644 | chr15:55130350-55130351 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs118052891 | chr15:55130362-55130363 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs12900206 | chr15:55130377-55130378 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs527401409 | chr15:55130386-55130387 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs181376999 | chr15:55130453-55130454 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs567332248 | chr15:55130456-55130457 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs530276944 | chr15:55130489-55130490 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs142311435 | chr15:55130515-55130516 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs146398295 | chr15:55130525-55130526 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs185752751 | chr15:55130562-55130563 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs1813885 | chr15:55130574-55130575 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs559012762 | chr15:55130579-55130580 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs566042392 | chr15:55130611-55130612 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs534998069 | chr15:55130613-55130614 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Schizophrenia | 19415332 | CNVD |
Breast cancer | 22522925 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
cataract | 16735990 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Medulloblastoma | 21979893 | CNVD |
spastic paraplegia with thinning of corpus callosum | 19105190 | CNVD |
Schizophrenia | 21324950 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Disease | 21824424 | CNVD |
Melanoma | 18172304 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Gastric cancer | 17167181 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Intellectual disability | 22102821 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Prostate cancer | 16573809 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Prostate cancer | 18632612 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Breast cancer | 22032731 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Cancer | 21129771 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Abnormal phenotypes | 18644119 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 17133270 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cancer | 17440070 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr15:55117600-55131800 | Weak transcription | Aorta | Aorta |
2 | chr15:55131000-55131800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
3 | chr15:55131000-55132400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
4 | chr15:55131200-55132400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
5 | chr15:55131200-55133200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
6 | chr15:55131200-55133200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
7 | chr15:55131800-55132000 | Flanking Active TSS | Aorta | Aorta |
8 | chr15:55131800-55132800 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
9 | chr15:55131800-55133200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
10 | chr15:55132000-55132200 | Active TSS | Aorta | Aorta |
11 | chr15:55132000-55133200 | Enhancers | H9 Cell Line | embryonic stem cell |
12 | chr15:55132000-55133200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
13 | chr15:55132400-55132800 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
14 | chr15:55132800-55133200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
15 | chr15:55133000-55133200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
16 | chr15:55133000-55133200 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
17 | chr15:55133000-55133200 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
18 | chr15:55134200-55136200 | Enhancers | Primary monocytes fromperipheralblood | blood |
19 | chr15:55134400-55134600 | Enhancers | Skeletal Muscle Female | skeletal muscle |